Simultaneous analysis of irbesartan and hydrochlorothiazide: An improved HPLC method with the aid of a chemometric protocol

Molecules

Volumn 17, Issue 3, 2012, Pages 3461-3474

  Vujić, Zorica ^a   Mulavdić, Nedžad ^b   Smajić, Miralem ^b   Brborić, Jasmina ^a   Stankovic, Predrag ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF TUZLA   (Bosnia and Herzegovina)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Experimental design; HPLC; Hydrochlorothiazide; Irbesartan

Indexed keywords

BIPHENYL DERIVATIVE; HYDROCHLOROTHIAZIDE; IRBESARTAN; TETRAZOLE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY;

BIPHENYL COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROCHLOROTHIAZIDE; MOLECULAR STRUCTURE; TETRAZOLES;

EID: 84858958219     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17033461     Document Type: Article

References (22)

1. Burnier, M.; Brunner, H. R. Angiotensin II receptor antagonists. Lancet 2000, 355, 637-645. (Pubitemid 30099477)
2. Rosangluaia; Shanmugasundaram, P.; Malarkodi, V. Validated HPTLC method for simultaneous estimation of irbesartan and hydrochlorthiazide in a tablet dosage form. der Pharm. Chem. 2011, 3, 310-317.
3. Shah, N. J.; Suhagia, B. N.; Shah, R. R.; Patel, N. M. Development and validation of a HPTLC method for the simultaneous estimation of irbesartan and hydrochlorothiazide in tablet dosage form. Indian J. Pharm. Sci. 2007, 69, 240-243.
4. Amol, S. K.; Laxman, V. P.; Mrinalini, C. D.; Kailash, G. B. A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide. Pharm. Methods 2010, 1, 39-43.
5. Mehta, B. H.; Morge, S. B. Simultaneous determination of irbesartan and hydrochlorothiazide by HPTLC method. Indian Drugs 2010, 47, 71-74.
6. Patel, K. R.; Patel, S. A.; Darji, V. C.; Sonpal, R. N. Simultaneous spectrophotometric determination of irbesartan and hydrochlorothiazide in tablets. Int. Res. J. Pharm. 2011, 2, 202-207.
7. Farouk, M.; Abd ELAziz, O.; Hemdan, A.; Shehata, M. Spectrofluorimetric methods for determination of some anti-hypertensive drugs. J. Am. Sci. 2011, 7, 300-312.
8. Ramzia, I. E.-B.; Hanaa, M. H.; Waleed, A. E. Spectrofluorometric, spectrophotometric and LC determination of irbesartan. J. Chem. Pharm. Res. 2011, 3, 722-733.
9. Burçin, B.; Burcu, D. T.; Bengi, U.; Sibel, A. Ö.; Hassan, Y. A.-E. Quantitative analysis of irbesartan in pharmaceuticals and human biological fluids by voltammetry. Anal. Lett. 2009, 42, 2322-2338.
10. Hillaert, S.; van den Bossche, W. Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis. J. Pharm. Biomed. Anal. 2003, 31, 329-339. (Pubitemid 36254815)
11. Farouk, M.; Abd ELAziz, O.; Hemdan, A.; Shehata, M. Novel validated chromatographic method for determination of some anti-hypertensive drugs. J. Am. Sci. 2010, 6, 476-486.
12. Gonzalez, L.; Lopez, J. A.; Alonso, R. M.; Jimenez, R. M. Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection. J. Chromatogr. A 2002, 949, 49-60. (Pubitemid 34183413)
13. Ganesan, M.; Nanjundan, S.; Gomathi, M.; Muralidharan, S. Method development and validation of Irbesartan using LCMS/MS: Application to pharmacokinetic studies. J. Chem. Pharm. Res. 2010, 2, 740-746.
14. Tutunji, L. F.; Tutunji, M. F.; Alzoubi, M. I.; Khabbas, M. H.; Arida, A. I. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectroscopy, application to bioeqivalance study. J. Pharm. Biomed. Anal. 2010, 51, 985-990.
15. Hillaert, S.; Van Den Bossche, W. Optimization and validation of a capillary zone electrophoretic method for the analysis of several angiotensin-II-receptor antagonists. J. Chromatogr. A 2002, 979, 323-333. (Pubitemid 35341558)
16. Hillaert, S.; de Beer, T. R. M.; de Beer, J. O.; van den Bossche, W. Optimization and validation of a micellar electrokinetic chromatographic method for the analysis of several angiotensin-II-receptor antagonists. J. Chromatogr. A 2003, 984, 135-146. (Pubitemid 35453935)
17. Ferreirós, N.; Iriarte, G.; Alonso, R. M.; Jiménez, R. M. MultiSimplex and experimental design as chemometric tools to optimize a SPE-HPLC-UV method for the determination of eprosartan in human plasma samples. Talanta 2006, 69, 747-756.
18. Torrealdaya, N.; Gonzáleza, L.; Alonso, R. M.; Jiméneza, R. M.; Ortiz Lastra, E. Experimental design approach for the optimisation of a HPLC-fluorimetric method for the quantitation of the angiotensin II receptor antagonist telmisartan in urine. J. Pharm. Biomed. Anal. 2003, 32, 847-857. (Pubitemid 36951960)
19. Gotardo, M. A.; Pezza, L.; Pezza, H. R. Determination of hydrochlorothiazide in pharmaceutical formulations by diffuse reflectance spectroscopy. Eclet. Quim. 2005, 30, 17-24. (Pubitemid 41727350)
20. Silva Sangoi, M.; Wrasse-Sangoi, M.; Renato de Oliveira, P.; Todeschini Clarice, V.; Bueno Rolim, M. Rapid simultaneous determination of aliskiren and hydrochlorothiazide from their pharmaceutical formulations bz monolithic silica HPLC column employing experimental design. J. Liq. Chromatogr. Relat. Technol. 2011, 34, 1976-1996.
21. Demiralaya, E. C.; Cubuka, B.; Ozkanb, S. A.; Alsancaka, G. Combined effect of polarity and pH on the chromatographic behavior of some angiotensin II receptor antagonists and optimization of their determination in pharmaceutical dosage forms. J. Pharm. Biomed. Anal. 2010, 53, 475-482.
22. Jocić, B.; Zecević, M.; Zivanović, L. J.; Protić, A.; Jadranin, M.; Vajs, V. Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method. J. Pharm. Biomed. Anal. 2008, 46, 622-629.